Liraglutide therapy in Prader‐Willi syndrome
2011; Wiley; Volume: 28; Issue: 6 Linguagem: Inglês
10.1111/j.1464-5491.2011.03280.x
ISSN1464-5491
AutoresKatarzyna Cyganek, Teresa Koblik, Elżbieta Kozek, Małgorzata Wójcik, Jerzy Starzyk, Maciej T. Małecki,
Tópico(s)Pancreatic function and diabetes
ResumoDiabetic MedicineVolume 28, Issue 6 p. 755-756 Letter to the Editor Liraglutide therapy in Prader-Willi syndrome K. Cyganek, K. Cyganek University HospitalSearch for more papers by this authorT. Koblik, T. Koblik University HospitalSearch for more papers by this authorE. Kozek, E. Kozek University Hospital Department of Metabolic Diseases, Jagiellonian University, Medical CollegeSearch for more papers by this authorM. Wojcik, M. Wojcik Department of Paediatric and Adolescent Endocrinology, Polish-American Pediatric Institute, Jagiellonian University, Medical College, Krakow, PolandSearch for more papers by this authorJ. Starzyk, J. Starzyk Department of Paediatric and Adolescent Endocrinology, Polish-American Pediatric Institute, Jagiellonian University, Medical College, Krakow, PolandSearch for more papers by this authorM. T. Malecki, M. T. Malecki University Hospital Department of Metabolic Diseases, Jagiellonian University, Medical CollegeSearch for more papers by this author K. Cyganek, K. Cyganek University HospitalSearch for more papers by this authorT. Koblik, T. Koblik University HospitalSearch for more papers by this authorE. Kozek, E. Kozek University Hospital Department of Metabolic Diseases, Jagiellonian University, Medical CollegeSearch for more papers by this authorM. Wojcik, M. Wojcik Department of Paediatric and Adolescent Endocrinology, Polish-American Pediatric Institute, Jagiellonian University, Medical College, Krakow, PolandSearch for more papers by this authorJ. Starzyk, J. Starzyk Department of Paediatric and Adolescent Endocrinology, Polish-American Pediatric Institute, Jagiellonian University, Medical College, Krakow, PolandSearch for more papers by this authorM. T. Malecki, M. T. Malecki University Hospital Department of Metabolic Diseases, Jagiellonian University, Medical CollegeSearch for more papers by this author First published: 09 March 2011 https://doi.org/10.1111/j.1464-5491.2011.03280.xCitations: 18Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Lovshin JA, Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 2009; 5: 262– 269. 2 Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009; 374: 1606– 1616. 3 Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93: 2670– 2678. 4 Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the diagnosis and management of Prader–Willi syndrome; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. J Clin Endocrinol Metab 2008; 93: 4183– 4197. 5 Pérez-Tilve D, González-Matías L, Alvarez-Crespo M, Leiras R, Tovar S, Diéguez C et al. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes 2007; 56: 143– 151. Citing Literature Volume28, Issue6June 2011Pages 755-756 ReferencesRelatedInformation
Referência(s)